Načítá se...
A hepatitis B virus transgenic mouse model with a conditional, recombinant, episomal genome
BACKGROUND & AIMS: Development of new and more effective therapies against hepatitis B virus (HBV) is limited by the lack of suitable small animal models. The HBV transgenic mouse model containing an integrated overlength 1.3-mer construct has yielded crucial insights, but this model unfortunate...
Uloženo v:
| Vydáno v: | JHEP Rep |
|---|---|
| Hlavní autoři: | , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Elsevier
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7940981/ https://ncbi.nlm.nih.gov/pubmed/33733079 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jhepr.2021.100252 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|